SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes inspection at Piramal Pharma’s PPDS Ahmedabad facility

13 Jul 2024 Evaluate

United States Food and Drug Administration (USFDA) has conducted a Pre-Approval Inspection (PAI) of Piramal Pharma’s PPDS Ahmedabad facility from July 10, 2024 to July 12, 2024. The inspection was completed successfully with Zero Form - 483 observations and No Action Indicated (NAI) designation.

Successful completion of this wholistic inspection at PPDS Ahmedabad facility, will now enable access to the company's high-end analytical capabilities to its customers for their clinical and commercial batches from an FDA approved site. The company remains committed to maintain the highest standards of compliance. 

Piramal Pharma provides end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.


Piramal Pharma Share Price

150.60 1.85 (1.24%)
21-Apr-2026 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.70
Dr. Reddys Lab 1220.00
Cipla 1232.60
Zydus Lifesciences 928.05
Lupin 2305.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×